Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that
protect against severe disease and preferably drive herd immunity. Regulators in numerous …
protect against severe disease and preferably drive herd immunity. Regulators in numerous …
[HTML][HTML] COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
Abstracts Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine
has garnered immense global interest. Less than a year after COVID-19 was declared a …
has garnered immense global interest. Less than a year after COVID-19 was declared a …
Access to and equitable distribution of COVID-19 vaccine in low-income countries
The ongoing Coronavirus Disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 still
poses significant health challenges globally. The Harvard group's models predict that a …
poses significant health challenges globally. The Harvard group's models predict that a …
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Since the first case of COVID-19 was identified in the USA in January, 2020, over 46 million
people in the country have tested positive for SARS-CoV-2 infection. Several COVID-19 …
people in the country have tested positive for SARS-CoV-2 infection. Several COVID-19 …
Addressing challenges to rolling out COVID-19 vaccines in African countries
JB Nachega, NA Sam-Agudu, R Masekela… - The Lancet Global …, 2021 - thelancet.com
There is much ongoing debate and concern regarding access to COVID-19 vaccines and
roll-out gaps in low-income and middle-income countries compared with high-income …
roll-out gaps in low-income and middle-income countries compared with high-income …
[HTML][HTML] Access to COVID-19 vaccines: looking beyond COVAX
T Lancet - Lancet (London, England), 2021 - ncbi.nlm.nih.gov
Global health leaders have been in a congratulatory mood. On March 1, they celebrated the
first vaccinations against COVID-19 in Africa delivered through COVAX—the scheme led by …
first vaccinations against COVID-19 in Africa delivered through COVAX—the scheme led by …
COVID-19 vaccines for low-and middle-income countries
EM Choi - Transactions of the Royal Society of Tropical …, 2021 - academic.oup.com
The COVID-19 pandemic is the biggest threat to public health in a century. Through hard
work and ingenuity, scientists have developed a number of safe and effective vaccines …
work and ingenuity, scientists have developed a number of safe and effective vaccines …
Global COVID-19 vaccine inequity: failures in the first year of distribution and potential solutions for the future
V Pilkington, SM Keestra, A Hill - Frontiers in Public Health, 2022 - frontiersin.org
Within the first year of distribution of vaccines against COVID-19, high-income countries
(HICs) have achieved vaccination rates of 75-80%, whilst low-income countries (LICs) …
(HICs) have achieved vaccination rates of 75-80%, whilst low-income countries (LICs) …
Challenges in the rollout of COVID-19 vaccines worldwide
TK Burki - The Lancet Respiratory Medicine, 2021 - thelancet.com
On Feb 24, 2021, 600 000 doses of the Oxford–AstraZeneca COVID-19 vaccine arrived in
Ghana. 2 days later, 500 000 doses of the same vaccine landed in the Ivory Coast. The west …
Ghana. 2 days later, 500 000 doses of the same vaccine landed in the Ivory Coast. The west …
Global COVID-19 vaccine inequity
T Burki - The Lancet Infectious Diseases, 2021 - thelancet.com
On May 27, 2021, the WHO Strategic Advisory Group of Experts on Immunization (SAGE)
convened to discuss COVID-19 vaccines. 15 vaccines are currently in use (the Oxford …
convened to discuss COVID-19 vaccines. 15 vaccines are currently in use (the Oxford …